Recombinant adeno-associated viral (rAAV) vectors are frequently used for gene delivery to the central nervous system and are capable of transducing neurons and glia in the rodent brain. In collaboration with Dr. Ania Majewska (U Rochester), we compared AAV serotype transduction in mouse cortex using an AAV vector expressing the green fluorescent protein. We identified serotypes capable of transducing neurons in mouse cortex and labeling them extensively to the endpoint of identifying dendritic spines. These neurons could be imaged in vivo using two photon microscopy and the same neurons could be imaged over several days. This establishes a method to monitor changes in cortical neuron morphology during development and in response to trauma, disease or drugs of abuse. Our results were published this year. In collaboration with Dr. Nigel Grieg (NIA), we have investigated the neuroprotective effects of activating the Glucagon-like peptide-1 receptor (GLP-1R). This year we published the protective effects of GLP1R receptor agonists (GLP-1 and exendin-4) against neurodegeneration in rodent models of stroke and Parkinsons disease and the results. We are currently developing an AAV vector expressing exendin-4 for further exploring therapeutic strategies including inducible expression. In addition, we are identifying methods of delivery AAV via the ventricular system for gene delivery of Exe-4 in several models of neurodegeneration including stroke, Alzheimers and ALS. This work in ongoing. As part of a collaboration on a primary project of Dr. Barry Hoffer (NIDA), we are examining the neuroprotective effects of conserved dopaminergic neurotrophic factor (CDNF) in a mouse model of Parkinsons disease. We are examining whether CDNF protein or an AAV-CDNF can confer neuroprotection and neuroregeneration in against neurotoxicity caused by MPTP. This work is ongoing. We are currently investigating the mechanisms of Mesencephalic astrocyte-derived neurotrophic factor (MANF)-mediated neuroprotection in a rodent model of stroke. Using an AAV vector expressing MANF, we can reduce ischemic brain injury. Using this model and evidence that MANF may be a mediator of the unfolded protein response (UPR) to endoplasmic reticulum stress, we are examining the molecular mechanism of MANF neuroprotection. We are also conducting cell culture experiments and C. elegans experiments to address the protective mechanisms of MANF as it relates to its function in ER stress. The phenomenon of ER stress occurs in many diseases beyond neurodegenerative and understanding its role may lead to broader therapeutic strategies. This work is ongoing.

Project Start
Project End
Budget Start
Budget End
Support Year
9
Fiscal Year
2009
Total Cost
$188,635
Indirect Cost
Name
National Institute on Drug Abuse
Department
Type
DUNS #
City
State
Country
Zip Code
Mätlik, Kert; Anttila, Jenni E; Kuan-Yin, Tseng et al. (2018) Poststroke delivery of MANF promotes functional recovery in rats. Sci Adv 4:eaap8957
Anttila, Jenni E; Albert, Katrina; Wires, Emily S et al. (2018) Post-stroke Intranasal (+)-Naloxone Delivery Reduces Microglial Activation and Improves Behavioral Recovery from Ischemic Injury. eNeuro 5:
Yu, Seong-Jin; Airavaara, Mikko; Wu, Kuo-Jen et al. (2017) 9-cis retinoic acid induces neurorepair in stroke brain. Sci Rep 7:4512
Baldwin, Heather A; Koivula, Pyry P; Necarsulmer, Julie C et al. (2017) Step Sequence Is a Critical Gait Parameter of Unilateral 6-OHDA Parkinson's Rat Models. Cell Transplant 26:659-667
Song, Kang-Ho; Fan, Alexander C; Hinkle, Joshua J et al. (2017) Microbubble gas volume: A unifying dose parameter in blood-brain barrier opening by focused ultrasound. Theranostics 7:144-152
Wallace, Veronica J; Cimbro, Raffaello; Rubio, F Javier et al. (2017) Neurons Internalize Functionalized Micron-Sized Silicon Dioxide Microspheres. Cell Mol Neurobiol 37:1487-1499
Koskela, Maryna; Bäck, Susanne; Võikar, Vootele et al. (2017) Update of neurotrophic factors in neurobiology of addiction and future directions. Neurobiol Dis 97:189-200
Howard, Douglas B; Harvey, Brandon K (2017) Assaying the Stability and Inactivation of AAV Serotype 1 Vectors. Hum Gene Ther Methods 28:39-48
Anttila, Jenni E; Whitaker, Keith W; Wires, Emily S et al. (2017) Role of microglia in ischemic focal stroke and recovery: focus on Toll-like receptors. Prog Neuropsychopharmacol Biol Psychiatry 79:3-14
Wires, Emily S; Henderson, Mark J; Yan, Xiaokang et al. (2017) Longitudinal monitoring of Gaussia and Nano luciferase activities to concurrently assess ER calcium homeostasis and ER stress in vivo. PLoS One 12:e0175481

Showing the most recent 10 out of 50 publications